| اسم المنتج |
Capreomycin |
| الاسم بالانجليزية |
Capreomycin;Capastat; Capostatin; Capreomicina; Capreomicina [INN-Spanish]; Capreomycine; Capreomycine [INN-French]; Capreomycinum; Capreomycinum [INN-Latin]; Caprolin; Capromycin; HSDB 3211; Kapreomycin; UNII-232HYX66HC; (3S)-3,6-diamino-N-{[(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl]methyl}hexanamide - (3S)-3,6-diamino-N-({(2S,5S,8E,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide (1:1); 3,6-diamino-N-{[(8Z)-15-amino-11-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl]methyl}hexanamide sulfate (salt); 3,6-diamino-N-{[(8E)-15-amino-11-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl]methyl}hexanamide sulfate (salt) |
| الصيغة الجزيئية |
C25H46N14O12S |
| الوزن الجزيئي الغرامي |
766.7843 |
| InChI |
InChI=1/C25H44N14O8.H2O4S/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-5(2,3)4/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);(H2,1,2,3,4)/b15-9+; |
| إستراتيجية المساعدة القطرية |
11003-38-6 |
| المفوضية الأوروبية رقم |
215-776-8 |
| بنية جزيئية |
|
| نقطة الغليان |
1376.7°C at 760 mmHg |
| نقطة الوميض |
786.4°C |
| ضغط البخار |
0mmHg at 25°C |
| علامات على البضائع الخطرة |
|
| خطر المصطلحات |
|
| شروط الأمن |
|
|
